Analysts expect that Transcat, Inc. (NASDAQ:TRNS) will report earnings of $0.19 per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Transcat’s earnings. Transcat reported earnings of $0.20 per share in the same quarter last year, which would suggest a negative year over year growth rate of 5%. The firm is scheduled to announce its next earnings results on Tuesday, October 22nd.
On average, analysts expect that Transcat will report full-year earnings of $0.92 per share for the current financial year. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that follow Transcat.
Transcat (NASDAQ:TRNS) last announced its quarterly earnings data on Tuesday, July 23rd. The scientific and technical instruments company reported $0.23 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.02). The company had revenue of $42.40 million during the quarter. Transcat had a return on equity of 12.84% and a net margin of 4.46%.
Several brokerages have recently issued reports on TRNS. ValuEngine downgraded shares of Transcat from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research downgraded shares of Transcat from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 30th.
Shares of Transcat stock opened at $23.35 on Friday. The company’s fifty day simple moving average is $24.29 and its 200-day simple moving average is $24.08. The company has a market cap of $167.16 million, a price-to-earnings ratio of 24.58, a PEG ratio of 3.11 and a beta of 0.72. The company has a current ratio of 2.10, a quick ratio of 1.38 and a debt-to-equity ratio of 0.44. Transcat has a 1 year low of $17.56 and a 1 year high of $27.00.
In related news, Director Richard J. Harrison sold 4,000 shares of the firm’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $24.22, for a total value of $96,880.00. Following the completion of the transaction, the director now directly owns 32,221 shares of the company’s stock, valued at $780,392.62. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, VP Robert A. Flack sold 8,962 shares of the firm’s stock in a transaction on Tuesday, June 4th. The stock was sold at an average price of $24.54, for a total value of $219,927.48. Following the completion of the transaction, the vice president now directly owns 27,103 shares of the company’s stock, valued at $665,107.62. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,462 shares of company stock valued at $842,642. 8.90% of the stock is owned by company insiders.
A number of hedge funds have recently modified their holdings of the stock. Marshall Wace North America L.P. lifted its position in Transcat by 157.5% in the first quarter. Marshall Wace North America L.P. now owns 1,545 shares of the scientific and technical instruments company’s stock worth $36,000 after purchasing an additional 945 shares during the period. Strs Ohio bought a new position in Transcat in the second quarter worth $46,000. O Shaughnessy Asset Management LLC lifted its position in Transcat by 12.1% in the first quarter. O Shaughnessy Asset Management LLC now owns 16,851 shares of the scientific and technical instruments company’s stock worth $387,000 after purchasing an additional 1,813 shares during the period. Howe & Rusling Inc. lifted its position in Transcat by 40.4% in the first quarter. Howe & Rusling Inc. now owns 6,950 shares of the scientific and technical instruments company’s stock worth $160,000 after purchasing an additional 2,000 shares during the period. Finally, BlackRock Inc. lifted its position in Transcat by 11.4% in the fourth quarter. BlackRock Inc. now owns 25,976 shares of the scientific and technical instruments company’s stock worth $494,000 after purchasing an additional 2,654 shares during the period. 60.71% of the stock is owned by hedge funds and other institutional investors.
Transcat, Inc provides calibration and laboratory instrument services in North America and internationally. It operates in two segments, Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.